Does TALAZOPARIB Cause Thrombocytopenia? 78 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 78 reports of Thrombocytopenia have been filed in association with TALAZOPARIB (Talzenna). This represents 5.3% of all adverse event reports for TALAZOPARIB.
78
Reports of Thrombocytopenia with TALAZOPARIB
5.3%
of all TALAZOPARIB reports
17
Deaths
33
Hospitalizations
How Dangerous Is Thrombocytopenia From TALAZOPARIB?
Of the 78 reports, 17 (21.8%) resulted in death, 33 (42.3%) required hospitalization, and 10 (12.8%) were considered life-threatening.
Is Thrombocytopenia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TALAZOPARIB. However, 78 reports have been filed with the FAERS database.
What Other Side Effects Does TALAZOPARIB Cause?
Anaemia (219)
Neoplasm progression (169)
Death (142)
Off label use (78)
Fatigue (77)
Platelet count decreased (68)
Haemoglobin decreased (65)
Febrile neutropenia (60)
Pancytopenia (60)
Nausea (53)
What Other Drugs Cause Thrombocytopenia?
DEXAMETHASONE (5,873)
RITUXIMAB (4,810)
CYCLOPHOSPHAMIDE (4,669)
LENALIDOMIDE (4,584)
CARBOPLATIN (4,483)
METHOTREXATE (3,865)
DOXORUBICIN (3,638)
ETOPOSIDE (3,085)
VINCRISTINE (2,940)
OXALIPLATIN (2,886)
Which TALAZOPARIB Alternatives Have Lower Thrombocytopenia Risk?
TALAZOPARIB vs TALC
TALAZOPARIB vs TALIGLUCERASE ALFA
TALAZOPARIB vs TALIMOGENE LAHERPAREPVEC
TALAZOPARIB vs TALQUETAMAB
TALAZOPARIB vs TALQUETAMAB-TGVS